Levi Blazer, PhD
Technical Advisor, Protein Sciences
Levi Blazer has over 10 years’ experience in drug discovery and has spent over 15 years in scientific research. He obtained his PhD in pharmacology from the University of Michigan, Ann Arbor, MI, USA, where he developed the first reversible inhibitors of the Regulator of G-protein Signaling (RGS) proteins. He continued his small molecule drug discovery career by co-founding the molecular screening department at Cayman Chemical in Ann Arbor, MI. After observing the immense potential of recombinant antibodies, he shifted focus from small molecules to biologics, joining the Toronto Recombinant Antibody Centre (TRAC) where he studied antibody engineering under the guidance of Sachdev Sidhu. At TRAC, Levi focused on multivalent antibody modalities with a special emphasis on antibody “developability.” He also oversaw the team responsible for the production and biophysical characterization of thousands of recombinant Fabs, IgG, and various other antibody modalities. Levi has published 27 articles in peer-reviewed journals including eLife and Nature Communications and holds two patents.